Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 17,600
+230 (1.32%)
Apr 10, 2026, 3:30 PM KST
Chabiotech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -109,876 | -4,764 | -8,431 | -47,543 | -13,968 |
Depreciation & Amortization | 56,293 | 45,009 | 37,799 | 32,520 | 27,862 |
Loss (Gain) From Sale of Assets | -29,361 | -21,904 | 26.53 | -138.34 | 657.11 |
Asset Writedown & Restructuring Costs | 41,043 | 1,132 | 453.62 | 329 | -101.17 |
Loss (Gain) From Sale of Investments | -962.52 | 1,681 | -1,492 | 9,505 | 1,343 |
Loss (Gain) on Equity Investments | -7,001 | -16,739 | -8,475 | 18,198 | -1,963 |
Stock-Based Compensation | 201.48 | 256.84 | 190.95 | 484.6 | 482.21 |
Provision & Write-off of Bad Debts | 1,147 | 1,153 | -172.95 | -145.79 | -339.14 |
Other Operating Activities | 31,258 | -27,967 | 8,066 | -20,208 | 25,616 |
Change in Accounts Receivable | -10,288 | -10,127 | -2,933 | -1,687 | -13,068 |
Change in Inventory | -5,650 | -3,845 | -1,521 | -9,617 | -475.24 |
Change in Accounts Payable | -5,728 | -5,223 | 27,403 | 25,884 | 964.89 |
Change in Other Net Operating Assets | -33,179 | -6,906 | -37,896 | -26,981 | -761.72 |
Operating Cash Flow | -72,104 | -48,244 | 13,018 | -19,399 | 26,248 |
Operating Cash Flow Growth | - | - | - | - | -44.15% |
Capital Expenditures | -146,985 | -93,947 | -70,365 | -120,355 | -112,598 |
Sale of Property, Plant & Equipment | 46,458 | 6,364 | 30.67 | 3,274 | 1,350 |
Cash Acquisitions | -87,192 | - | -3,129 | -21,266 | -355.55 |
Divestitures | 10,727 | 18,532 | - | - | - |
Sale (Purchase) of Intangibles | -4,709 | -4,058 | -3,067 | -8,337 | -2,857 |
Investment in Securities | 67,574 | 51,820 | -5,518 | 50,638 | 16,184 |
Other Investing Activities | -26,273 | 28,654 | -1,672 | 429.21 | -12,212 |
Investing Cash Flow | -140,400 | 7,365 | -83,721 | -95,616 | -110,315 |
Short-Term Debt Issued | 46,214 | 144,953 | 15,373 | 4,218 | 1,800 |
Long-Term Debt Issued | 106,200 | 348,106 | 84,949 | 82,049 | 57,314 |
Total Debt Issued | 152,414 | 493,058 | 100,322 | 86,267 | 59,114 |
Short-Term Debt Repaid | -13,388 | -110,433 | -3,073 | -1,800 | -1,000 |
Long-Term Debt Repaid | -96,001 | -135,480 | -69,436 | -32,911 | -26,256 |
Total Debt Repaid | -109,390 | -245,913 | -72,509 | -34,711 | -27,256 |
Net Debt Issued (Repaid) | 43,024 | 247,145 | 27,814 | 51,556 | 31,859 |
Issuance of Common Stock | 181,731 | 199.9 | 26,642 | 99.65 | 1,445 |
Repurchase of Common Stock | - | -53.11 | -3,010 | - | - |
Common Dividends Paid | -418.99 | -1,302 | -1,507 | -1,231 | -4,019 |
Dividends Paid | -418.99 | -1,302 | -1,507 | -1,231 | -4,019 |
Other Financing Activities | -1,453 | -77,397 | 16,431 | 21,028 | 45,032 |
Financing Cash Flow | 222,883 | 212,738 | 66,369 | 71,453 | 76,105 |
Foreign Exchange Rate Adjustments | -8,229 | 2,854 | -1,575 | -12,355 | 9,318 |
Miscellaneous Cash Flow Adjustments | -0 | - | -0 | -0 | 0 |
Net Cash Flow | 2,151 | 174,713 | -5,908 | -55,918 | 1,356 |
Free Cash Flow | -219,089 | -142,191 | -57,346 | -139,754 | -86,350 |
Free Cash Flow Margin | -17.27% | -13.61% | -6.01% | -16.55% | -11.87% |
Free Cash Flow Per Share | -3264.11 | -4477.42 | -1004.83 | -2483.78 | -1584.36 |
Cash Interest Paid | 39,163 | 24,420 | 2,189 | 4,133 | 4,494 |
Cash Income Tax Paid | 5,679 | 6,548 | 2,493 | 15,621 | 10,048 |
Levered Free Cash Flow | -161,693 | -58,635 | -179,722 | -78,383 | -11,777 |
Unlevered Free Cash Flow | -127,414 | -35,407 | -161,534 | -65,341 | -2,694 |
Change in Working Capital | -54,845 | -26,101 | -14,947 | -12,402 | -13,340 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.